편집
13,656
번
새 문서: An Open-Label Extension Trial of Ranibizumab for Choroidal Neovascularization Secondary to Age-Related Macular Degeneration (HORIZON) == 연구의 목적 == 장기간 라니비주...
(새 문서: An Open-Label Extension Trial of Ranibizumab for Choroidal Neovascularization Secondary to Age-Related Macular Degeneration (HORIZON) == 연구의 목적 == 장기간 라니비주...) |
(차이 없음)
|